Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan for non-hypovolemic non-acute hyponatremia
CTR20131274Phase 3Active
- Sponsor
- Hengrui Therapeutics
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tolvaptan in hyponatraemia, sponsored by Hengrui Therapeutics. Started Mar 2014; status: active.
02
Drugs
tolvaptan
03
Conditions
hyponatraemia
Beyond the preview
Go deeper on CTR20131274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131274.